Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 61.94M | 2.42 | $ 25.55M |
3/31/2025 | $ 48.29M | 1.69 | $ 28.5M |
12/31/2024 | $ 17.5M | 0.7 | $ 24.95M |
9/30/2024 | $ 29.96M | 1.53 | $ 19.64M |
6/30/2024 | $ 19.33M | 1.1 | $ 17.64M |
3/31/2024 | $ 18.87M | 1.26 | $ 15.01M |
12/31/2023 | $ 45.03M | 2.24 | $ 20.12M |
9/30/2023 | $ 76.49M | 3.88 | $ 19.7M |
6/30/2023 | $ 141.09M | 7.87 | $ 17.93M |
3/31/2023 | $ 185.88M | 9.32 | $ 19.95M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ATAI LIFE SCIENCES NV is calculated as follows: CashnEq [ $ 97.25M ] / LiabilitesC [ $ 12.3M ]
(=) Cash Ratio [ 7.91 ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |